Discover high-conviction stock picks and new investing opportunities with the TipRanks Smart Investor Newsletter
Liquidia Technologies (LQDA)
Raymond James analyst Ryan Deschner maintained a Buy rating on Liquidia Technologies today. The company’s shares closed last Thursday at $62.54.
According to TipRanks.com, Deschner is a 5-star analyst with an average return of 37.1% and a 62.0% success rate. Deschner covers the Healthcare sector, focusing on stocks such as Dianthus Therapeutics, Mirum Pharmaceuticals, and Vera Therapeutics.
Liquidia Technologies has an analyst consensus of Strong Buy, with a price target consensus of $64.83.
